CHICAGO (Reuters) - Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that ...

For the first time in Nepal, genetic testing, also known as "Gene Sequencing," related to breast cancer (BRCA1 and BRCA2) has ...

Scientists have analyzed thousands of mutations in the BRCA2 cancer gene, offering crucial insights. This research could help mitigate patient concerns or guide tailored treatments. By utilizing ...

It's been long known that women with BRCA1 and BRCA2 gene mutations are at higher risk for breast and ovarian cancer. More than 60% of women who inherit a BRCA mutation will develop breast cancer ...

By filling the gaps on testing and giving people with harmful mutations better ways to reduce their risk, BRCA1 and BRCA2 testing could become a model for how genetic tests for other cancer risk ...

Learn vital signs of male breast cancer, risk factors, and treatment options as new research highlights the importance of ...

The benefit of RRSO on overall survival varied by the BRCA gene that was mutated, with a greater survival benefit for patients with germline mutations in BRCA1 than in BRCA2 (56% vs. 15% lower ...

Anyone looking into genetic testing for cancer should seek support from a genetic counselor; you don't know what kind of ...

SAN ANTONIO – Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...